微生物群中的病原生物:疾病的驱动因素和治疗的目标
Selvaraj Bharathi1, Yolin Angel P A Soundara Rajan2, Santhiyagu Prakash3
1Centre for Modern Organic Agriculture Research (CMOAR), Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India.
Microbial pathogenesis
|December 29, 2025
概括
病原生物,通常是无害的微生物,可以引起疾病由于诸如失能和免疫问题的因素. 本综述探讨了它们在各种疾病中的作用,并讨论了基于微生物组的治疗方法.
科学领域:
- 微生物组研究的研究.
- 免疫学 免疫学 免疫学
- 传染病 传染病 传染病 传染病
背景情况:
- 病原生物是具有致病潜力的共生微生物.
- 出现与失能,抗生素,饮食,免疫功能障碍和宿主遗传学有关.
- 它们会影响肠道,口腔和阴道微生物组.
研究的目的:
- 审查驱动病原生物出现的因素.
- 突出病原生物在疾病发病和免疫障碍中的作用.
- 讨论当前和先进的治疗策略.
主要方法:
- 关于病原生物及其影响的文献综述.
- 对影响病原生物行为因素的分析.
- 治疗干预措施的评估.
主要成果:
- 病原生物的出现是多因素的.
- 在肠道,口腔,阴道健康和与免疫系统相关的疾病中发挥重要作用.
- 像FMT,菌体疗法,益生菌和益生菌等疗法显示出有希望的结果.
结论:
- 需要针对性,基于微生物组的干预措施.
- 了解病原生物生态和宿主免疫力至关重要.
- 综合方法对于管理与病原生物有关的疾病至关重要.
更多相关视频
相关概念视频
Microorganisms in Medicine and Therapeutics
911
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
911
Infection
11.6K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.6K
Fungal Phylum Microsporidia
374
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
374
Defense Against Bacterial Pathogens
2.6K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.6K
Gene Regulation in Microbial Communities: Quorum Sensing
457
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
457
Targets for Drug Action: Overview
9.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K


